REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/15/2026
Back to search
Official data from USPTO
ABSIEVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/15/2026
Trademark type
Word
Nice classes
42
Filing date
04/11/2016
Registration date
08/15/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/12/2025
Last transaction
08/15/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
Plzen, CZ
Examiner
O'ROURKE, JONATHAN RYAN
Current location
Historical data usage
Holders and representatives
Holders
A. S. (pessoa física)
Representatives
Karen L. Elbing CLARK & ELBING LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research projects for the preparation of peptide and antibody librariesfor identification and characterization of binding moleculesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparationidentification and characterisation of peptides and antibodiesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodiessingle-chain antibodiesdiabodiestandabsflexibodiestriabodiestetrabodiesbivalent antibodiesmultivalent antibodieswhole immunoglobulinsantibody fragmentsin particular Fab and scFv fragmentsof nucleic acid sequences coding for these moleculesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to antibody discoveryscientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of naturalengineered and immunized librariesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to screening of antibody librariesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to phage displayphage panning and yeast display vectorsscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection processscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectorsscientific research and analysis in the field of antibody discovery; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic applicationscientific research and analysis in the field of antibody research and drug design
Publications
History of USPTO decisions and trademark events.
30 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/12/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/08/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2017
PUBO
PUBLISHED FOR OPPOSITION
05/30/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/25/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/16/2017
GNRT
NON-FINAL ACTION E-MAILED
03/16/2017
CNRT
NON-FINAL ACTION WRITTEN
03/16/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2017
ALIE
ASSIGNED TO LIE
02/16/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/02/2016
GNRT
NON-FINAL ACTION E-MAILED
08/02/2016
CNRT
NON-FINAL ACTION WRITTEN
08/02/2016
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/29/2016
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/29/2016
DOCK
ASSIGNED TO EXAMINER
07/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2016
NWAP
NEW APPLICATION ENTERED
04/14/2016
Continuous trademark protection
Get notified about every new filing that threatens ABSIEVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.